We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+22.08%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$301M
AUM Growth
+$15.1M
Cap. Flow
-$2.12M
Cap. Flow %
-0.71%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IL
IntraLinks Holdings Inc.
IL
+$2.12M

Sector Composition

Rank Sector Weight
1 Healthcare 21.63%
2 Technology 17.32%
3 Communication Services 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAC
1
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$126M 41.75%
1,067,892
IL
2
DELISTED
IntraLinks Holdings Inc.
IL
$52.1M 17.32%
6,290,503
-200,000
-3% -$2.12M
TVRD
3
Tvardi Therapeutics
TVRD
$24M
$38.1M 12.66%
74,113
EVDY
4
DELISTED
Everyday Health, Inc.
EVDY
$37.5M 12.47%
4,107,522
RCKT icon
5
Rocket Pharmaceuticals
RCKT
$358M
$27M 8.96%
717,646
MGNI icon
6
Magnite
MGNI
$2.57B
$11.6M 3.85%
798,381
RLOC
7
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$5.42M 1.8%
2,570,395
NRX
8
DELISTED
NEPHROGENEX INC COM
NRX
$3.56M 1.18%
1,052,966

Similar funds

Rho Capital Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Rho Capital Partners held 8 positions worth $301M, up 5.3% from $286M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2015: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 16% a quarter earlier, followed by Technology and Communication Services.

  • Rho Capital Partners's biggest Q3 2015 reduction was IntraLinks Holdings Inc., cutting an estimated $2.12M.
  • Rho Capital Partners's ten largest holdings make up 100% of its $301M portfolio in Q3 2015.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q3 2015.
  • Rho Capital Partners's portfolio value rose 5.3% quarter-over-quarter to $301M.

Based on Rho Capital Partners's 13F filing for Q3 2015, filed 3 Nov 2015.